231 related articles for article (PubMed ID: 38081445)
1. In vitro dose-dependent effects of matrix metalloproteinases on ECM hydrogel biodegradation.
Didwischus N; Guduru A; Badylak SF; Modo M
Acta Biomater; 2024 Jan; 174():104-115. PubMed ID: 38081445
[TBL] [Abstract][Full Text] [Related]
2. Biodegradation of ECM hydrogel promotes endogenous brain tissue restoration in a rat model of stroke.
Ghuman H; Mauney C; Donnelly J; Massensini AR; Badylak SF; Modo M
Acta Biomater; 2018 Oct; 80():66-84. PubMed ID: 30232030
[TBL] [Abstract][Full Text] [Related]
3. Post-Stroke Timing of ECM Hydrogel Implantation Affects Biodegradation and Tissue Restoration.
Damian C; Ghuman H; Mauney C; Azar R; Reinartz J; Badylak SF; Modo M
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768800
[TBL] [Abstract][Full Text] [Related]
4. Long-term retention of ECM hydrogel after implantation into a sub-acute stroke cavity reduces lesion volume.
Ghuman H; Gerwig M; Nicholls FJ; Liu JR; Donnelly J; Badylak SF; Modo M
Acta Biomater; 2017 Nov; 63():50-63. PubMed ID: 28917705
[TBL] [Abstract][Full Text] [Related]
5. Concentration-dependent rheological properties of ECM hydrogel for intracerebral delivery to a stroke cavity.
Massensini AR; Ghuman H; Saldin LT; Medberry CJ; Keane TJ; Nicholls FJ; Velankar SS; Badylak SF; Modo M
Acta Biomater; 2015 Nov; 27():116-130. PubMed ID: 26318805
[TBL] [Abstract][Full Text] [Related]
6. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
7. Initial immune response to a FRET-based MMP sensor-immobilized silk fibroin hydrogel in vivo.
Kambe Y; Yamaoka T
Acta Biomater; 2021 Aug; 130():199-210. PubMed ID: 34087439
[TBL] [Abstract][Full Text] [Related]
8. Spatiotemporal neocartilage growth in matrix-metalloproteinase-sensitive poly(ethylene glycol) hydrogels under dynamic compressive loading: an experimental and computational approach.
Schneider MC; Lalitha Sridhar S; Vernerey FJ; Bryant SJ
J Mater Chem B; 2020 Apr; 8(14):2775-2791. PubMed ID: 32155233
[TBL] [Abstract][Full Text] [Related]
9. Impact of Inter- and Intra-Donor Variability by Age on the Gel-to-Tissue Transition in MMP-Sensitive PEG Hydrogels for Cartilage Regeneration.
Maples MM; Schneider MC; Bryant SJ
ACS Appl Bio Mater; 2023 Jul; 6(7):2677-2689. PubMed ID: 37367934
[TBL] [Abstract][Full Text] [Related]
10. A hydrogel derived from decellularized dermal extracellular matrix.
Wolf MT; Daly KA; Brennan-Pierce EP; Johnson SA; Carruthers CA; D'Amore A; Nagarkar SP; Velankar SS; Badylak SF
Biomaterials; 2012 Oct; 33(29):7028-38. PubMed ID: 22789723
[TBL] [Abstract][Full Text] [Related]
11. Mapping the acute time course of immune cell infiltration into an ECM hydrogel in a rat model of stroke using
Modo M; Ghuman H; Azar R; Krafty R; Badylak SF; Hitchens TK
Biomaterials; 2022 Mar; 282():121386. PubMed ID: 35093825
[TBL] [Abstract][Full Text] [Related]
12. Metalloproteinases: A parade of functions in matrix biology and an outlook for the future.
Apte SS; Parks WC
Matrix Biol; 2015; 44-46():1-6. PubMed ID: 25916966
[TBL] [Abstract][Full Text] [Related]
13. An in vitro and in vivo comparison of cartilage growth in chondrocyte-laden matrix metalloproteinase-sensitive poly(ethylene glycol) hydrogels with localized transforming growth factor β3.
Schneider MC; Chu S; Randolph MA; Bryant SJ
Acta Biomater; 2019 Jul; 93():97-110. PubMed ID: 30914256
[TBL] [Abstract][Full Text] [Related]
14. Diamagnetic chemical exchange saturation transfer (diaCEST) affords magnetic resonance imaging of extracellular matrix hydrogel implantation in a rat model of stroke.
Jin T; Nicholls FJ; Crum WR; Ghuman H; Badylak SF; Modo M
Biomaterials; 2017 Jan; 113():176-190. PubMed ID: 27816001
[TBL] [Abstract][Full Text] [Related]
15. The role of matrix metalloproteinases in regulating neuronal and nonneuronal cell invasion into PEGylated fibrinogen hydrogels.
Sarig-Nadir O; Seliktar D
Biomaterials; 2010 Sep; 31(25):6411-6. PubMed ID: 20537384
[TBL] [Abstract][Full Text] [Related]
16. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
Kim IS; Yang WS; Kim CH
Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of matrix metalloprotease sensitive-low molecular weight hyaluronic acid based hydrogels.
Kim J; Park Y; Tae G; Lee KB; Hwang SJ; Kim IS; Noh I; Sun K
J Mater Sci Mater Med; 2008 Nov; 19(11):3311-8. PubMed ID: 18496734
[TBL] [Abstract][Full Text] [Related]
18. Sustained Release of a Peptide-Based Matrix Metalloproteinase-2 Inhibitor to Attenuate Adverse Cardiac Remodeling and Improve Cardiac Function Following Myocardial Infarction.
Fan Z; Fu M; Xu Z; Zhang B; Li Z; Li H; Zhou X; Liu X; Duan Y; Lin PH; Duann P; Xie X; Ma J; Liu Z; Guan J
Biomacromolecules; 2017 Sep; 18(9):2820-2829. PubMed ID: 28731675
[TBL] [Abstract][Full Text] [Related]
19. Incorporating a structural extracellular matrix gradient into a porcine urinary bladder matrix-based hydrogel dermal scaffold.
Allbritton-King JD; Kimicata M; Fisher JP
J Biomed Mater Res A; 2021 Oct; 109(10):1893-1904. PubMed ID: 33797180
[TBL] [Abstract][Full Text] [Related]
20. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration.
Gaide Chevronnay HP; Selvais C; Emonard H; Galant C; Marbaix E; Henriet P
Biochim Biophys Acta; 2012 Jan; 1824(1):146-56. PubMed ID: 21982799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
